IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study

Morano Amado, Luis

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/585

ISSN: 0270-9139

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2012

Journal title

Hepatology

Type of content

Publicación de congreso